XML 27 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2018
Accounting Policies [Abstract]  
Schedule of basic and diluted loss per common share using weighted-average shares outstanding

The net loss from continuing operations and the weighted average number of shares used in computing basic and diluted net loss per share from continuing operations for the three months ended March 31, 2018 and 2017, is as follows:

 

    Three Months Ended March 31,  
    2018     2017  
             
Numerator:                
Net loss   $

1,650

 

    $

1,849

 

 
Net gain (loss) from discontinued operations attributable to common stockholders     79      

(1,849

 

)
Accretion of Series B Preferred Stock to redemption value (*)     1,968        
Preferred dividend on Series B Preferred Stock (**)     79        
Participation of stockholders of Series A Preferred Stock in the net loss from continuing operations    

(357

 

)      
                 
Net loss from continuing operations attributable to common stockholders   $

3,419

 

    $  
                 
Denominator:                
Shares of common stock used in computing basic and diluted net loss per share     11,868,619       4,237,517  
                 
Net loss per share of common stock from continuing operations, basic and diluted   $

0.29

 

    $  
 
  (*) Based on the rights and privileges of Series B Preferred Stock, since the Company did not obtain shareholder approval at March 31, 2018, the then outstanding Series B Preferred Stock became redeemable at the option of OFI.

 

  (**) The net loss used for the computation of basic and diluted net loss per share for three months ended March 31, 2018, includes the preferred dividend requirement of 8% per share per annum for the Series B Preferred Stock, compounded annually which shall be distributed to stockholders in case of distributable assets determined in the Company’s certificate of designation under the liquidation preference right (see also Note 5).